Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2012; 107(06): 1193
DOI: 10.1160/TH12-02-0114
DOI: 10.1160/TH12-02-0114
Author Correspondence
Erythropoietin, progenitor cells and restenosis. A critique of Stein et al.
Further Information
Publication History
Received:
25 February 2012
Accepted:
04 March 2012
Publication Date:
29 November 2017 (online)
-
References
- 1 Stein A, Mohr F, Laux M. et al. Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis. Thromb Haemost 2012; 107: 769-774.
- 2 Ott I, Schulz S, Mehilli J. et al. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circ Cardiovasc Interv 2010; 3: 408-413.
- 3 Ozawa T, Toba K, Suzuki H. et al. Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction – randomized controlled pilot trial of EPO/AMI-1 study. Circ J 2010; 74: 1415-1423.
- 4 Taniguchi N, Nakamura T, Sawada T. et al. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study. Circ J 2010; 74: 2365-2371.
- 5 Voors AA, Belonje AM, Zijlstra F. et al. A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J 2010; 31: 2593-2600.
- 6 Opie LH. Erythropoietin as a cardioprotective agent: down but not out. Heart 2011; 97: 1537-1539.